title: Serum TABM produced during anterior chamber-associated immune deviation passively transfers suppression of delayed-type hypersensitivity to primed mice.
abstract: Injection of soluble protein antigen into the anterior chamber of the eye of primed mice induces anterior chamber-associated immune deviation (ACAID) which is manifested by suppression of delayed-type hypersensitivity (DTH) to the antigen. Recently, we found that ACAID induced in primed mice also results in a rapid rise in serum of soluble T lymphocyte-derived proteins specific for nominal antigen (TABM). Here, we demonstrate that serum TABM induced in primed mice during ACAID will transfer the suppression of DTH to mice primed to the same antigen. Sera from TNP-BSA-primed mice that received an anterior chamber injection of TNP-BSA, but not BSA alone, suppressed the DTH response to TNP when injected into other TNP-BSA-primed mice. Sera absorbed with Sepharose beads conjugated with either anti-TCR C(alpha), anti-TCR C(beta), anti-TABM or TNP-BSA did not contain TNP-specific TABM and did not transfer suppression of DTH. These results suggest that the antigen-specific, TCR C(alphabeta)+ TABM that appear in serum during ACAID are able to confer on or amplify the capacity of sensitized T cells to suppress DTH. We believe this to be the first demonstration of an in vivo immunologic function that is specifically associated with TABM produced in vivo.
authors.affiliation: Vision Immunology Center, Department of Pathology, University of Connecticut Health Center, Farmington 06030-3105, USA.
authors.forename: Y
authors.initials: Y
authors.lastname: Wang
authors.forename: J
authors.initials: J
authors.lastname: O'Rourke
authors.forename: R E
authors.initials: RE
authors.lastname: Cone
mesh_terms: D000042:Absorption; D000818:Animals; D000867:Anterior Chamber / Q000187:drug effects / Q000276:immunology*; D001798:Blood Proteins / Q000096:biosynthesis* / Q000276:immunology* / Q000378:metabolism; D000939:Epitopes / Q000276:immunology; D005260:Female; D006968:Hypersensitivity, Delayed / Q000209:etiology / Q000276:immunology*; D007106:Immune Sera / Q000276:immunology / Q000378:metabolism; D007116:Immunization, Passive; D007166:Immunosuppressive Agents / Q000276:immunology* / Q000494:pharmacology; D051379:Mice; D008807:Mice, Inbred BALB C; D010081:Oxazolone / Q000276:immunology* / Q000494:pharmacology*; D010853:Picryl Chloride / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000276:immunology; D012709:Serum Albumin / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology / Q000378:metabolism*; D014302:Trinitrobenzenesulfonic Acid / Q000276:immunology
chemical_list: D001798:Blood Proteins; D000939:Epitopes; D007106:Immune Sera; D007166:Immunosuppressive Agents; D011948:Receptors, Antigen, T-Cell; D012709:Serum Albumin; D010081:Oxazolone; D014302:Trinitrobenzenesulfonic Acid; D010853:Picryl Chloride